Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

Condition:   Metastatic Castration-resistant Prostate Cancer Intervention:   Drug: Phase I and Phase II: LAE001/prednisone + afuresertib Sponsor:   Laekna Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials